V-Square Quantitative Management
MRNA icon

V-Square Quantitative Management’s Moderna MRNA Stock Holding History

V-Square Quantitative Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$554K Sell
2,877
-3,655
-56% -$394K 0.05% 318
2026
Q2 		$457K Buy
6,532
+1,528
+31% +$79.1K 0.04% 353
2026
Q1 		$254K Sell
5,004
-4,994
-50% -$233K 0.03% 489
2025
Q4 		$295K Sell
9,998
-513
-5% -$13.9K 0.03% 441
2025
Q3 		$271K Buy
10,511
+390
+4% +$10.9K 0.05% 168
2025
Q2 		$279K Buy
10,121
+2,614
+35% +$68.8K 0.04% 433
2025
Q1 		$213K Sell
7,507
-290
-4% -$10.3K 0.03% 489
2024
Q4 		$324K Buy
7,797
+2,148
+38% +$103K 0.05% 398
2024
Q3 		$378K Buy
5,649
+2,838
+101% +$261K 0.06% 367
2024
Q2 		$334K Sell
2,811
-967
-26% -$122K 0.05% 342
2024
Q1 		$403K Buy
3,778
+1,280
+51% +$129K 0.06% 317
2023
Q4 		$248K Buy
2,498
+666
+36% +$56K 0.04% 349
2023
Q3 		$189K Buy
+1,832
New +$204K 0.08% 378

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Patton Fund Management
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

V-Square Quantitative Management's MRNA Position: Q3 2026 in Review

V-Square Quantitative Management reduced its Moderna (MRNA) stake by 56% in Q3 2026, selling an estimated $394K and leaving 2,877 shares worth $554K. The position accounts for 0.05% of the portfolio, ranked #318.

V-Square Quantitative Management first reported a position in MRNA in Q3 2023 and has held it in 13 quarters since. 154 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • V-Square Quantitative Management held 2,877 shares of Moderna worth $554K as of Q3 2026.
  • V-Square Quantitative Management sold 3,655 Moderna shares in Q3 2026, an estimated $394K.
  • Moderna made up 0.05% of V-Square Quantitative Management's portfolio in Q3 2026, its #318 holding.
  • V-Square Quantitative Management first reported a position in Moderna in Q3 2023 and has held it in 13 quarters since.
  • 154 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.